Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Meropenem
Related studies linked through entity extraction aliases.
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Antibiotics Continuous Infusion at Home
- Status
- UNKNOWN
- Phase
- PHASE1
Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
- Status
- UNKNOWN
- Phase
- PHASE4
Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins
- Status
- COMPLETED
- Phase
- PHASE3
Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS
- Status
- COMPLETED
- Phase
- N/A
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
- Status
- WITHDRAWN
- Phase
- PHASE3
Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
- Status
- UNKNOWN
- Phase
- N/A
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
- Status
- SUSPENDED
- Phase
- PHASE4
PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections
- Status
- COMPLETED
- Phase
- PHASE3
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
- Status
- COMPLETED
- Phase
- PHASE3
suPAR to Guide Antibiotics in Emergency Department
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
- Status
- RECRUITING
- Phase
- PHASE4
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Pharmacokinetics of Meropenem During High-dose CRRT
- Status
- COMPLETED
- Phase
- N/A
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
- Status
- COMPLETED
- Phase
- PHASE2
CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
- Status
- COMPLETED
- Phase
- PHASE3
Bolus Versus Continuous Infusion of Meropenem
- Status
- COMPLETED
- Phase
- PHASE4